Description |
AL-108 is the first drug to improve memory performance by impacting the mechanisms that lead to physical damage in the brain caused by neurofibrillary tangles, one of the two established pathological hallmarks that are common to amnestic mild cognitive impairment (aMCI) and Alzheimer's disease (AD). AL-108 is derived from a naturally occurring neuroprotective brain protein known as activity dependent neuroprotective protein.
|
